MedTrace Logo

Shanghai At Risk for Alzheimer's Disease: a Cohort Study

NCT05597410 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3418

Last updated 2022-10-28

No results posted yet for this study

Summary

The goal of this cohort study is to estimate the incidence of AD in the first-degree relatives of patients with AD. The main questions it aims to answer are:

* cognitive changes of subjects at high risk of AD as ageing;
* environmental and behavioral factors affecting AD incidence.

Conditions

Sponsors & Collaborators

  • Ruijin Hospital

    lead OTHER

Principal Investigators

  • Gang Wang, MD, PhD · Ruijin Hospital

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2029-03-31
Completion
2030-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05597410 on ClinicalTrials.gov